Correction to: Molecular Psychiatry advance online publication, 29 November 2016; doi: 10.1038/mp.2016.204
The ninth and eleventh authors’ affiliations were presented incorrectly. They should have been linked to the following affiliations:
A Llerena - 7CICAB Clinical Research Center, Extremadura University Hospital and Medical School, Badajoz, Spain. 8CIBERSAM, Madrid, Spain. EM Peñas-Lledó - 7CICAB Clinical Research Center, Extremadura University Hospital and Medical School, Badajoz, Spain.
Additional information
The online version of the original article can be found at 10.1038/mp.2016.204
Rights and permissions
About this article
Cite this article
Jukić, M., Opel, N., Ström, J. et al. Erratum: Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment. Mol Psychiatry 22, 1224 (2017). https://doi.org/10.1038/mp.2017.93
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2017.93
This article is cited by
-
A view of response and resistance to atomoxetine treatment in children with ADHD: effects of CYP2C19 polymorphisms and BDNF levels
European Journal of Clinical Pharmacology (2022)
